U.S. Markets closed
  • S&P Futures

    4,064.75
    -10.75 (-0.26%)
     
  • Dow Futures

    33,999.00
    -24.00 (-0.07%)
     
  • Nasdaq Futures

    12,045.50
    -61.25 (-0.51%)
     
  • Russell 2000 Futures

    1,906.30
    -4.20 (-0.22%)
     
  • Crude Oil

    81.30
    +0.29 (+0.36%)
     
  • Gold

    1,927.40
    -2.60 (-0.13%)
     
  • Silver

    23.95
    -0.07 (-0.29%)
     
  • EUR/USD

    1.0883
    -0.0009 (-0.0871%)
     
  • 10-Yr Bond

    3.4930
    +0.0310 (+0.90%)
     
  • Vix

    18.73
    -0.35 (-1.83%)
     
  • GBP/USD

    1.2396
    -0.0011 (-0.0868%)
     
  • USD/JPY

    129.6980
    -0.4550 (-0.3496%)
     
  • BTC-USD

    22,830.24
    -393.35 (-1.69%)
     
  • CMC Crypto 200

    517.33
    -9.86 (-1.87%)
     
  • FTSE 100

    7,761.11
    +16.24 (+0.21%)
     
  • Nikkei 225

    27,381.18
    +18.43 (+0.07%)
     

Biogen and Eisai’s Alzheimer’s Data Confirm Benefit. Questions Still Loom.

Biogen and Eisai’s Alzheimer’s Data Confirm Benefit. Questions Still Loom.

Japan's Eisai, which is developing the treatment with the U.S. pharmaceutical company, said in a September press release that the therapy worked surprisingly well.